Oxford Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Oxford Asset Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$22.1M	Buy	461,016 +75,038	+19%	+$3.49M	3.12%	7
2019 Q4	$18.1M	Buy	+385,978	New	+$17.1M	0.5%	20
2019 Q2	–	Sell	-80,681	Closed	-$1.81M	–	2077
2019 Q1	$1.81M	Sell	80,681 -27,911	-26%	-$600K	0.04%	627
2018 Q4	$1.98M	Buy	108,592 +17,418	+19%	+$273K	0.05%	470
2018 Q3	$1.66M	Buy	91,174 +54,617	+149%	+$647K	0.03%	770
2018 Q2	$366K	Sell	36,557 -114,394	-76%	-$790K	0.01%	1444
2018 Q1	$802K	Buy	150,951 +92,946	+160%	+$664K	0.02%	1042
2017 Q4	$493K	Sell	58,005 -10,421	-15%	-$128K	0.01%	1184
2017 Q3	$1.01M	Buy	68,426 +1,088	+2%	+$16.4K	0.02%	936
2017 Q2	$1.26M	Buy	+67,338	New	+$1.52M	0.03%	807

Other funds holding RARX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oxford Asset Management's RARX Position: Q1 2020 in Review

Oxford Asset Management increased its Ra Pharmaceuticals, Inc. Common Stock (RARX) stake by 19% in Q1 2020, buying an estimated $3.49M and bringing the position to 461,016 shares worth $22.1M. The position accounts for 3.12% of the portfolio, ranked #7.

Oxford Asset Management first reported a position in RARX in Q2 2017 and has held it in 10 quarters since. 144 funds tracked by Wall St. Rank hold RARX as of Q1 2020.

Oxford Asset Management held 461,016 shares of Ra Pharmaceuticals, Inc. Common Stock worth $22.1M as of Q1 2020.
Oxford Asset Management bought 75,038 Ra Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $3.49M.
Ra Pharmaceuticals, Inc. Common Stock made up 3.12% of Oxford Asset Management's portfolio in Q1 2020, its #7 holding.
Oxford Asset Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q2 2017 and has held it in 10 quarters since.
144 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.